<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ssmu</journal-id><journal-title-group><journal-title xml:lang="ru">Бюллетень сибирской медицины</journal-title><trans-title-group xml:lang="en"><trans-title>Bulletin of Siberian Medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1682-0363</issn><issn pub-type="epub">1819-3684</issn><publisher><publisher-name>Siberian State Medical University, the Ministry of Healthcare of the Russian Federation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.20538/1682-0363-2021-4-25-31</article-id><article-id custom-type="elpub" pub-id-type="custom">ssmu-4576</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL PAPERS</subject></subj-group></article-categories><title-group><article-title>Влияние нетоза на лизис фибринового сгустка при раке толстого кишечника</article-title><trans-title-group xml:lang="en"><trans-title>he effects of NETosis on fibrinolysis in colon cancer patients</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1458-2385</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Паршина</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Parshina</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>аспирант, кафедра патологической физиологии, </p><p>672090, г. Чита, ул. Горького 39а</p></bio><bio xml:lang="en"><p>39a, Gorkogo Str., Chita, 672090</p></bio><email xlink:type="simple">a.parshina.csma@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0975-2351</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Цыбиков</surname><given-names>Н. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Tsybikov</surname><given-names>N. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д-р мед. наук, профессор, зав. кафедрой патологической физиологии, </p><p>672090, г. Чита, ул. Горького 39а</p></bio><bio xml:lang="en"><p>39a, Gorkogo Str., Chita, 672090</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8601-3499</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Терешков</surname><given-names>П. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Tereshkov</surname><given-names>P. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>канд. мед. наук, вед. науч. сотрудник, лаборатория клинической и экспериментальной биохимии и иммунологии, НИИ молекулярной медицины, </p><p>672090, г. Чита, ул. Горького 39а</p></bio><bio xml:lang="en"><p>39a, Gorkogo Str., Chita, 672090</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0487-6275</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Караваева</surname><given-names>Т. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Karavaeva</surname><given-names>T. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>канд. мед. наук, ст. науч. сотрудник, лаборатория клинической и экспериментальной биохимии и  иммунологии, НИИ молекулярной медицины, </p><p>672090, г. Чита, ул. Горького 39а</p></bio><bio xml:lang="en"><p>39a, Gorkogo Str., Chita, 672090</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6308-3411</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Максименя</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Maksimenya</surname><given-names>M. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p> канд. биол. наук, ст. науч. сотрудник, лаборатория клинической и экспериментальной биохимии и иммунологии, НИИ молекулярной медицины, </p><p>672090, г. Чита, ул. Горького 39а</p></bio><bio xml:lang="en"><p>39a, Gorkogo Str., Chita, 672090</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Читинская государственная медицинская академия (ЧГМА)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Chita State Medical Academy (CSMA)</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>01</day><month>01</month><year>2022</year></pub-date><volume>20</volume><issue>4</issue><fpage>25</fpage><lpage>31</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Паршина А.А., Цыбиков Н.Н., Терешков П.П., Караваева Т.М., Максименя М.В., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Паршина А.А., Цыбиков Н.Н., Терешков П.П., Караваева Т.М., Максименя М.В.</copyright-holder><copyright-holder xml:lang="en">Parshina A.A., Tsybikov N.N., Tereshkov P.P., Karavaeva T.M., Maksimenya M.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://bulletin.ssmu.ru/jour/article/view/4576">https://bulletin.ssmu.ru/jour/article/view/4576</self-uri><abstract><p>Цель – изучение особенностей формирования нейтрофильных внеклеточных ловушек, а также их влияния на фибринолиз у лиц, имеющих злокачественные новообразования толстого кишечника.</p><sec><title>Материалы и методы</title><p>Материалы и методы. Группу пациентов составили лица с впервые выявленным раком толстого кишечника 2–3-й стадии без метастаза (17 человек, средний возраст 67 лет); контрольную группу – доноры, сопоставимые по полу и возрасту, не имеющие злокачественных опухолей (30 человек, средний возраст 68 лет). Из цельной крови создали экспериментальную модель, включавшую бедную тромбоцитами плазму крови и изолированную культуру нейтрофилов, предварительно индуцированных к нетозу внесением 100 нмоль PMA, инкубировали 4 ч, клетки осаждали центрифугированием, плазму отбирали для дальнейшего исследования. В качестве контроля использовали плазму, инкубированную с интактными нейтрофилами. О степени активации клеток судили по уровню интерлейкина (IL) 8 и PSGL-1. Нетоз подтверждали измерением уровня нуклеосом и флуоресцентной микроскопией. Оценку фибринолиза проводили в тесте тромбодинамики. Результаты сопоставляли с концентрацией компонентов фибринолитической системы, измеренных методом проточной цитометрии.</p></sec><sec><title>Результаты</title><p>Результаты. В контроле индукция нетоза вызывает выраженную активацию нейтрофилов, сопровождающуюся повышением уровня IL-8, PSGL-1, плазминогена, снижением PAI-1 и усилением фибринолиза, в сравнении с интактными образцами. У пациентов зафиксирован больший, чем в группе контроля, уровень IL-8, PSGL-1, плазминогена, PAI-1 и показателей фибринолиза в интактных образцах. При этом индукция нетоза не привела к увеличению степени активации и значимому изменению данных показателей.</p></sec><sec><title>Заключение</title><p>Заключение. Гибель нейтрофилов путем нетоза в местах тромбообразования может способствовать как формированию, так и растворению фибринового сгустка. Однако у лиц со злокачественными новообразованиями «смертельный» нетоз не приводит к локальному увеличению фибринолитического потенциала ввиду истощения внутриклеточных резервов протеаз нейтрофилов, что может являться одним из механизмов развития гиперкоагуляции и недостаточности фибринолиза при онкопатологии. </p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Aim</title><p>Aim. To investigate formation of neutrophil extracellular traps (NETs) and their impact on fibrinolysis in patients with colon cancer.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. The study was performed in two groups. The experimental group consisted of patients with stage 2–3 non-metastatic colon cancer (n = 17, average age – 67 years). The control group included healthy volunteers matched by sex and age (n = 30, average age – 68 years). An experimental model was created from the whole blood. It included platelet-poor plasma and an isolated culture of neutrophils, previously induced to NETosis by adding 100 nmol PMA. The samples were incubated for 4 hours, then the test tubes were centrifuged to pellet cells and their remnants, and the plasma was transferred for subsequent examination. The plasma incubated with intact neutrophils was used as a control. The levels of interleukin-8 (IL-8) and P-selectin glycoprotein ligand-1 (PSGL-1) were used to determine the degree of cell activation. NETosis was confirmed by enzyme-linked immunosorbent assay (ELISA) and fluorescent microscopy. Fibrinolysis was assessed using the thrombodynamics test. The results were compared with the levels of fibrinolytic system components measured by flow cytometry.</p></sec><sec><title>Results</title><p>Results. In the control group, NETosis induction contributed to pronounced neutrophil activation that was accompanied by an increase in the IL-8, PSGL-1, and plasminogen levels, a decrease in PAI-1, and enhancement of fibrinolysis, compared with the intact samples. Higher levels of IL-8, PSGL-1, plasminogen, and PAI-1 and intensified fibrinolysis were detected in the intact samples. However, PMA-induced NETosis did not result in an increase in the degree of activation and significant changes in the given parameters.</p></sec><sec><title>Conclusion</title><p>Conclusion. NETosis promotes both formation and lysis of fibrin clots. However, in cancer patients, suicidal NETosis does not contribute to fibrinolysis due to intracellular protease depletion, which may be one of the mechanisms causing hypercoagulation and insufficient fibrinolysis in cancer. </p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>рак</kwd><kwd>нейтрофильные внеклеточные ловушки</kwd><kwd>фибринолиз</kwd><kwd>иммунотромбоз</kwd><kwd>нетоз</kwd><kwd>гиперкоагуляция.</kwd></kwd-group><kwd-group xml:lang="en"><kwd>cancer</kwd><kwd>neutrophil extracellular traps</kwd><kwd>fibrinolysis</kwd><kwd>immunothrombosis</kwd><kwd>NETosis</kwd><kwd>hypercoagulation</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Исследование выполнено при финансовой поддержке РФФИ (проект № 19-34-90050).</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Brinkmann V., Reichard U., Goosmann C., Fauler B., Uhlemann Y., Weiss D.S., Weinrauch Y., Zychlinsky A. Neutrophil extracellular traps kill bacteria. Science. 2004; 303 (5663): 1532–1535. DOI: 10.1126/science.1092385.</mixed-citation><mixed-citation xml:lang="en">Brinkmann V., Reichard U., Goosmann C., Fauler B., Uhlemann Y., Weiss D.S., Weinrauch Y., Zychlinsky A. Neutrophil extracellular traps kill bacteria. Science. 2004; 303 (5663): 1532–1535. DOI: 10.1126/science.1092385.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Fuchs T.A., Brill A., Duerschmied D., Schatzberg D., Monestier M., Myers D.D. Jr., Wrobleski S.K., Wakefield T.W., Hartwig J.H., Wagner D.D. Extracellular DNA traps promote thrombosis. PNAS. 2010; 107 (36): 15880–15888. DOI: 10.1073/pnas.1005743107.</mixed-citation><mixed-citation xml:lang="en">Fuchs T.A., Brill A., Duerschmied D., Schatzberg D., Monestier M., Myers D.D. Jr., Wrobleski S.K., Wakefield T.W., Hartwig J.H., Wagner D.D. Extracellular DNA traps promote thrombosis. PNAS. 2010; 107 (36): 15880–15888. DOI: 10.1073/pnas.1005743107.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Martinod K., Demers M., Fuchs T.A., Wong S.L., Brill A., Gallant M., Hu J., Wang Y., Wagner D.D. Neutrophil histone modification by peptidylarginine deiminase 4 is critical for deep vein thrombosis in mice. PNAS. 2013; 110 (21): 8674– 8679. DOI: 10.1073/pnas.1301059110.</mixed-citation><mixed-citation xml:lang="en">Martinod K., Demers M., Fuchs T.A., Wong S.L., Brill A., Gallant M., Hu J., Wang Y., Wagner D.D. Neutrophil histone modification by peptidylarginine deiminase 4 is critical for deep vein thrombosis in mice. PNAS. 2013; 110 (21): 8674– 8679. DOI: 10.1073/pnas.1301059110.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Czaikoski P.G., Mota J. M.S.C., Nascimento D.C., Sônego F., Castanheira F.V.e S., Melo P.H., Scortegagna G.T., Silva R.L., Barroso-Sousa R., Souto F.O., Pazin-Filho A., Figueiredo F., Alves-Filho J.C., Cunha F.Q. Neutrophil extracellular traps induce organ damage during experimental and clinical sepsis. PLoS One. 2016; 11 (2): e148142. DOI: 10.1371/journal.pone.0148142.</mixed-citation><mixed-citation xml:lang="en">Czaikoski P.G., Mota J. M.S.C., Nascimento D.C., Sônego F., Castanheira F.V.e S., Melo P.H., Scortegagna G.T., Silva R.L., Barroso-Sousa R., Souto F.O., Pazin-Filho A., Figueiredo F., Alves-Filho J.C., Cunha F.Q. Neutrophil extracellular traps induce organ damage during experimental and clinical sepsis. PLoS One. 2016; 11 (2): e148142. DOI: 10.1371/journal.pone.0148142.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Budnik I., Brill A. Immune factors in deep vein thrombosis initiation. Trends in Immunology. 2018; 39 (8): 610–623. DOI: 10.1016/j.it.2018.04.010.</mixed-citation><mixed-citation xml:lang="en">Budnik I., Brill A. Immune factors in deep vein thrombosis initiation. Trends in Immunology. 2018; 39 (8): 610–623. DOI: 10.1016/j.it.2018.04.010.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Grover S.P., Mackman N. Neutrophils, NETs, and immunothrombosis. Blood. 2018; 132 (13): 1360–1361. DOI: 10.1182/blood-2018-08-868067.</mixed-citation><mixed-citation xml:lang="en">Grover S.P., Mackman N. Neutrophils, NETs, and immunothrombosis. Blood. 2018; 132 (13): 1360–1361. DOI: 10.1182/blood-2018-08-868067.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Iba T., Hashiguchi N., Nagaoka I., Tabe Y., Murai M. Neutrophil cell death in response to infection and its relation to coagulation. Journal of Intensive Care. 2013; 1 (1): 13. DOI: 10.1186/2052-0492-1-13. 8. Федоткина Ю.А., Панченко Е.П. Тромбозы в онкологии. Часть 1. Атеротромбоз. 2017; 1: 11–15. DOI: 10.21518/2307-1109-2017-1-11-15.</mixed-citation><mixed-citation xml:lang="en">Iba T., Hashiguchi N., Nagaoka I., Tabe Y., Murai M. Neutrophil cell death in response to infection and its relation to coagulation. Journal of Intensive Care. 2013; 1 (1): 13. DOI: 10.1186/2052-0492-1-13. 8. Федоткина Ю.А., Панченко Е.П. Тромбозы в онкологии. Часть 1. Атеротромбоз. 2017; 1: 11–15. DOI: 10.21518/2307-1109-2017-1-11-15.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Falanga A., Schieppati F., Russo L. Pathophysiology 1. Mechanisms of thrombosis in cancer patients. In: Soff G. (eds) Thrombosis and hemostasis in cancer. Cancer Treatment and Research. 2019; 179: 11–36. DOI: 10.1007/978-3-030-20315-3_2.</mixed-citation><mixed-citation xml:lang="en">Falanga A., Schieppati F., Russo L. Pathophysiology 1. Mechanisms of thrombosis in cancer patients. In: Soff G. (eds) Thrombosis and hemostasis in cancer. Cancer Treatment and Research. 2019; 179: 11–36. DOI: 10.1007/978-3-030-20315-3_2.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Chennakrishnaiah S., Meehan B., D’Ast E., Montermini L., Lee T.H., Karatzas N., Buchanan M., Tawil N., Choi D., Divangahi M., Basik M., Rak J. Leukocytes as a reservoir of circulating oncogenic DNA and regulatory targets of tumor‐ derived extracellular vesicles. J. Thromb. Haemost. 2018; 16 (9): 1800–1813. DOI: 10.1111/jth.14222.</mixed-citation><mixed-citation xml:lang="en">Chennakrishnaiah S., Meehan B., D’Ast E., Montermini L., Lee T.H., Karatzas N., Buchanan M., Tawil N., Choi D., Divangahi M., Basik M., Rak J. Leukocytes as a reservoir of circulating oncogenic DNA and regulatory targets of tumor‐ derived extracellular vesicles. J. Thromb. Haemost. 2018; 16 (9): 1800–1813. DOI: 10.1111/jth.14222.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Таширева Л.А., Перельмутер В.М., Манских В.Н., Денисов Е.В. Савельева О.Е., Кайгородова Е.В., Завьялова М.В. Типы иммуновоспалительных реакций как алгоритмы взаимодействия клеток в условиях репаративной регенерации и опухолевого роста. Биохимия. 2017; 82 (5): 732–748.</mixed-citation><mixed-citation xml:lang="en">Таширева Л.А., Перельмутер В.М., Манских В.Н., Денисов Е.В. Савельева О.Е., Кайгородова Е.В., Завьялова М.В. Типы иммуновоспалительных реакций как алгоритмы взаимодействия клеток в условиях репаративной регенерации и опухолевого роста. Биохимия. 2017; 82 (5): 732–748.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Demers M., Wong S.L., Martinod K., Gallant M., Cabral E., Wang Y., Wagner D.D. Priming of neutrophils toward netosis promotes tumor growth. Oncoimmunology. 2016; 5 (5): e1134073. DOI: 10.1080/2162402X.2015.1134073.</mixed-citation><mixed-citation xml:lang="en">Demers M., Wong S.L., Martinod K., Gallant M., Cabral E., Wang Y., Wagner D.D. Priming of neutrophils toward netosis promotes tumor growth. Oncoimmunology. 2016; 5 (5): e1134073. DOI: 10.1080/2162402X.2015.1134073.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Shaul M.E., Fridlender Z.G. Cancer-related circulating and tumor-associated neutrophils –subtypes, sources and function. FEBS J. 2018; 285 (23): 4316–4342. DOI: 10.1111/ febs.14524.</mixed-citation><mixed-citation xml:lang="en">Shaul M.E., Fridlender Z.G. Cancer-related circulating and tumor-associated neutrophils –subtypes, sources and function. FEBS J. 2018; 285 (23): 4316–4342. DOI: 10.1111/ febs.14524.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Leal A.C., Mizurini D.M., Gomes T., Rochael N.C., Saraiva E.M., Dias M.S., Werneck C.C., Sielski M.S., Vicente C.P., Monteiro R.Q. Tumor-derived exosomes induce the formation of neutrophil traps: Implications for the establishment of cancer-associated thrombosis. Sci. Rep. 2017; 7 (1): 6438. DOI: 10.1038/s41598-017-06893-7.</mixed-citation><mixed-citation xml:lang="en">Leal A.C., Mizurini D.M., Gomes T., Rochael N.C., Saraiva E.M., Dias M.S., Werneck C.C., Sielski M.S., Vicente C.P., Monteiro R.Q. Tumor-derived exosomes induce the formation of neutrophil traps: Implications for the establishment of cancer-associated thrombosis. Sci. Rep. 2017; 7 (1): 6438. DOI: 10.1038/s41598-017-06893-7.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Thiam H.R., Wong S.L., Wagner D.D., Waterman C.M. Cellular Mechanisms of NETosis Annu. Rev. Cell Dev. Biol. 2020; 36: 191–218. DOI: 10.1146/annurev-cellbio-020520-111016.</mixed-citation><mixed-citation xml:lang="en">Thiam H.R., Wong S.L., Wagner D.D., Waterman C.M. Cellular Mechanisms of NETosis Annu. Rev. Cell Dev. Biol. 2020; 36: 191–218. DOI: 10.1146/annurev-cellbio-020520-111016.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Паршина А.А., Цыбиков Н.Н. Влияние нейтрофильных внеклеточных ловушек на коагуляционный гемостаз и фибринолиз у пациентов со злокачественными новообразованиями толстого кишечника. Забайкальский медицинский вестник. 2019; 4: 90–96.</mixed-citation><mixed-citation xml:lang="en">Паршина А.А., Цыбиков Н.Н. Влияние нейтрофильных внеклеточных ловушек на коагуляционный гемостаз и фибринолиз у пациентов со злокачественными новообразованиями толстого кишечника. Забайкальский медицинский вестник. 2019; 4: 90–96.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Damiana T., Damgaard D., Sidelmann J.J., Nielsen C.H., de Maat M.P., Münster A.M.B., Palarasah Y. Citrullination of fibrinogen by peptidylarginine deiminase 2 impairs fibrin clot structure. Clinica Chimica Acta. 2020; 501: 6–11. DOI: 10.1016/j.cca.2019.10.033.</mixed-citation><mixed-citation xml:lang="en">Damiana T., Damgaard D., Sidelmann J.J., Nielsen C.H., de Maat M.P., Münster A.M.B., Palarasah Y. Citrullination of fibrinogen by peptidylarginine deiminase 2 impairs fibrin clot structure. Clinica Chimica Acta. 2020; 501: 6–11. DOI: 10.1016/j.cca.2019.10.033.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Zhou Y., Chen B., Mittereder N., Chaerkady R., Strain M., An. L.-L., Rahman S., Ma W., Low C.P., Chan D., Neal F., Bingham III C.O., Sampson K., Darrah E., Siegel M.R., Hasni S., Andrade F., Vousden K.A., Mustelin T., Sims G.P. Spontaneous secretion of the citrullination enzyme PAD2 and cell surface exposure of PAD4 by neutrophils. Frontiers in Immunology. 2017; 8: 1200. DOI: 10.3389/fimmu.2017.01200.</mixed-citation><mixed-citation xml:lang="en">Zhou Y., Chen B., Mittereder N., Chaerkady R., Strain M., An. L.-L., Rahman S., Ma W., Low C.P., Chan D., Neal F., Bingham III C.O., Sampson K., Darrah E., Siegel M.R., Hasni S., Andrade F., Vousden K.A., Mustelin T., Sims G.P. Spontaneous secretion of the citrullination enzyme PAD2 and cell surface exposure of PAD4 by neutrophils. Frontiers in Immunology. 2017; 8: 1200. DOI: 10.3389/fimmu.2017.01200.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
